Lilly

The U.S. Food and Drug Administration has approved Eli Lilly's GLP-1 pill, the company said, a major milestone for…
Read More...

Eli Lilly has agreed to pay up to $7.8 billion to acquire Centessa Pharmaceuticals and its experimental drug for…
Read More...

A drone view shows the Eli Lilly logo on the company’s office in San Diego, California, Nov. 21, 2025.Mike Blake |…
Read More...

Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its production…
Read More...

An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024.Shelby…
Read More...

The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg |…
Read More...

Eli Lilly CEO Dave Ricks on Friday said upcoming Medicare coverage of obesity drugs could be a major catalyst for the…
Read More...

Eli Lilly Chair and CEO Dave Ricks speaks during a press conference in Houston, Sept. 23, 2025.Antranik Tavitian |…
Read More...

The booming GLP-1 space was built on weekly injections. In 2026, new obesity pills will push the market into its next…
Read More...

The Eli Lilly & Co. logo at the company's Digital Health Innovation Hub facility in Singapore, on Thursday, Nov.…
Read More...